Weekly Winners｜Albemarle Soared 18%; Eli Lilly Surged 11%; Cisco Jumped 10%

This week, which stocks lagged or dragged? Weekly Winners column keeps up with market trends, helping Tigers sort out the week's hottest sectors, stock winners and important news.

Below are top 10 S&P 500 stock gainers for the week ended Nov. 14:

Albemarle Gets Target Increases on Positive Lithium Outlook

Albemarle stands to benefit from a more positive outlook on the lithium market. "With lithium prices potentially moving higher near term, we see risk/reward as more balanced" for the company, UBS analyst Joshua Spector says in a note. Mizuho's John Roberts said that stationary storage now accounts for 20% of lithium demand, and is likely to increase alongside energy demands to power data centers. Mizuho raises its price target to $110 from $92, and UBS put it at $107, up from $85. Both, however, sit below the current share price of $114.26.

Eli Lilly stock reaches new high

Eli Lilly and Co.’s stock hit an all-time high and reached $1,025 per share this week in the wake of several significant deals and after it received fast-track regulatory review from the U.S. Food and Drug Administration for its highly anticipated weight-loss pill, orforglipron.

Cisco Raises Annual Forecast as AI Boom Spurs Networking Gear Demand

Cisco raised its forecast for full-year profit and revenue on Wednesday, banking on multi-billion-dollar data center expansions to drive demand for its networking equipment.

Companies such as Cisco have been reaping the benefits of businesses rapidly migrating workloads to the cloud and pouring billions into upgrading campus infrastructure in response to surging adoption of AI models.